72 related articles for article (PubMed ID: 35561088)
21. Noncanonical scaffolding of G
Smith JS; Pack TF; Inoue A; Lee C; Zheng K; Choi I; Eiger DS; Warman A; Xiong X; Ma Z; Viswanathan G; Levitan IM; Rochelle LK; Staus DP; Snyder JC; Kahsai AW; Caron MG; Rajagopal S
Science; 2021 Mar; 371(6534):. PubMed ID: 33479120
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth.
Hoy JJ; Salinas Parra N; Park J; Kuhn S; Iglesias-Bartolome R
FASEB J; 2020 Oct; 34(10):13900-13917. PubMed ID: 32830375
[TBL] [Abstract][Full Text] [Related]
23. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
Nizam E; Köksoy S; Erin N
Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
[TBL] [Abstract][Full Text] [Related]
24. IL6 Modulates the Immune Status of the Tumor Microenvironment to Facilitate Metastatic Colonization of Colorectal Cancer Cells.
Toyoshima Y; Kitamura H; Xiang H; Ohno Y; Homma S; Kawamura H; Takahashi N; Kamiyama T; Tanino M; Taketomi A
Cancer Immunol Res; 2019 Dec; 7(12):1944-1957. PubMed ID: 31554639
[TBL] [Abstract][Full Text] [Related]
25. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.
Gharaee N; Pourali L; Jafarian AH; Hashemy SI
Mol Biol Rep; 2018 Dec; 45(6):2257-2262. PubMed ID: 30225581
[TBL] [Abstract][Full Text] [Related]
27. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
28. The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway.
Niu XL; Hou JF; Li JX
Biol Res; 2018 May; 51(1):14. PubMed ID: 29843798
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory genes are novel prognostic biomarkers for colorectal cancer.
Jiang H; Dong L; Gong F; Gu Y; Zhang H; Fan D; Sun Z
Int J Mol Med; 2018 Jul; 42(1):368-380. PubMed ID: 29693170
[TBL] [Abstract][Full Text] [Related]
30. GPCRs: Emerging anti-cancer drug targets.
Nieto Gutierrez A; McDonald PH
Cell Signal; 2018 Jan; 41():65-74. PubMed ID: 28931490
[TBL] [Abstract][Full Text] [Related]
31. Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.
Suvas S
J Immunol; 2017 Sep; 199(5):1543-1552. PubMed ID: 28827386
[TBL] [Abstract][Full Text] [Related]
32. Lack of interleukin-6 in the tumor microenvironment augments type-1 immunity and increases the efficacy of cancer immunotherapy.
Ohno Y; Toyoshima Y; Yurino H; Monma N; Xiang H; Sumida K; Kaneumi S; Terada S; Hashimoto S; Ikeo K; Homma S; Kawamura H; Takahashi N; Taketomi A; Kitamura H
Cancer Sci; 2017 Oct; 108(10):1959-1966. PubMed ID: 28746799
[TBL] [Abstract][Full Text] [Related]
33. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms.
Gonzalez de Valdivia E; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
J Biol Chem; 2017 Jun; 292(24):9932-9943. PubMed ID: 28450397
[TBL] [Abstract][Full Text] [Related]
34. PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.
Sinha S; Fu YY; Grimont A; Ketcham M; Lafaro K; Saglimbeni JA; Askan G; Bailey JM; Melchor JP; Zhong Y; Joo MG; Grbovic-Huezo O; Yang IH; Basturk O; Baker L; Park Y; Kurtz RC; Tuveson D; Leach SD; Pasricha PJ
Cancer Res; 2017 Apr; 77(8):1868-1879. PubMed ID: 28386018
[TBL] [Abstract][Full Text] [Related]
35. β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G
Zhang YX; Li XF; Yuan GQ; Hu H; Song XY; Li JY; Miao XK; Zhou TX; Yang WL; Zhang XW; Mou LY; Wang R
J Biol Chem; 2017 May; 292(21):8933-8947. PubMed ID: 28341744
[TBL] [Abstract][Full Text] [Related]
36. G Protein-Coupled Receptors in Cancer.
Bar-Shavit R; Maoz M; Kancharla A; Nag JK; Agranovich D; Grisaru-Granovsky S; Uziely B
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529230
[TBL] [Abstract][Full Text] [Related]
37. Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.
González-Santana A; Marrero-Hernández S; Dorta I; Hernández M; Pinto FM; Báez D; Bello AR; Candenas L; Almeida TA
Fertil Steril; 2016 Nov; 106(6):1521-1529. PubMed ID: 27456549
[TBL] [Abstract][Full Text] [Related]
38. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
[TBL] [Abstract][Full Text] [Related]
39. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS.
Tack J; Schumacher K; Tonini G; Scartoni S; Capriati A; Maggi CA;
Gut; 2017 Aug; 66(8):1403-1413. PubMed ID: 27196574
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer.
Kuipers EJ; Grady WM; Lieberman D; Seufferlein T; Sung JJ; Boelens PG; van de Velde CJ; Watanabe T
Nat Rev Dis Primers; 2015 Nov; 1():15065. PubMed ID: 27189416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
